Literature DB >> 8738706

Retinopathy in diabetic hypertensive monkeys: a pathologic study.

E R Büchi1, A Kurosawa, M O Tso.   

Abstract

BACKGROUND: No satisfactory primate model of diabetic retinopathy has been produced. The clinical picture of microangiopathic retinopathy in diabetic hypertensive monkeys has been previously reported. The present study describes the pathologic findings of these animals.
METHODS: Eleven eyes of six monkeys (five rhesus, one cynomolgus) were studied. Diabetes mellitus was either spontaneous or induced by streptozocin; mild arterial hypertension was either spontaneous or induced by fludrocortisone acetate. In two monkeys, the horseradish peroxidase tracer technique was employed. Trypsin flat preparations of the nasal retinal vasculature were prepared. The material was studied by light and electron microscopy.
RESULTS: We divided the development of the microangiopathic retinopathy into three stages. In the early stage, background retinopathy was characterized by microvascular abnormalities and capillary dropout. Massive vascular leakage, intraretinal exudates and hemorrhage, cystoid degeneration, and cotton-wool spots were features of an exudative retinopathy in the second stage. In the final stage, chronic ischemic retinopathy was characterized by vascular occlusions and areas of retinal atrophy.
CONCLUSION: Microangiopathic retinopathy in diabetic monkeys with mild hypertension presented many features of human diabetic and hypertensive retinopathy, except vitreous neovascularization.

Entities:  

Mesh:

Year:  1996        PMID: 8738706     DOI: 10.1007/bf00190716

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  50 in total

1.  DEVELOPMENT AND SENESCENCE OF THE HUMAN RETINAL VASCULATURE.

Authors:  D G COGAN
Journal:  Trans Ophthalmol Soc U K       Date:  1963

2.  Animal modeling of cystoid macular edema.

Authors:  M O Tso
Journal:  Surv Ophthalmol       Date:  1984-05       Impact factor: 6.048

3.  Talc retinopathy in primates: a model of ischemic retinopathy. II. A histopathologic study.

Authors:  N Kaga; M O Tso; L M Jampol; T Setogawa; K R Rednam
Journal:  Arch Ophthalmol       Date:  1982-10

4.  Progression of incipient diabetic retinopathy during good glycemic control.

Authors:  R L Engerman; T S Kern
Journal:  Diabetes       Date:  1987-07       Impact factor: 9.461

5.  Absence of degenerative changes in retinal and uveal capillary pericytes in diabetic rats.

Authors:  R G Tilton; L S LaRose; C Kilo; J R Williamson
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-05       Impact factor: 4.799

6.  Fundus lesions in malignant hypertension. IV. Focal intraretinal periarteriolar transudates.

Authors:  S S Hayreh; G E Servais; P S Virdi
Journal:  Ophthalmology       Date:  1986-01       Impact factor: 12.079

7.  Fundus lesions in malignant hypertension. III. Arterial blood pressure, biochemical, and fundus changes.

Authors:  S S Hayreh; G E Servais; P S Virdi; M L Marcus; P Rojas; R F Woolson
Journal:  Ophthalmology       Date:  1986-01       Impact factor: 12.079

8.  Fundus lesions in malignant hypertension. I. A pathologic study of experimental hypertensive choroidopathy.

Authors:  S Kishi; M O Tso; S S Hayreh
Journal:  Arch Ophthalmol       Date:  1985-08

9.  The pathophysiology of experimental insulin-deficient diabetes in the monkey. Implications for pancreatic transplantation.

Authors:  O Jonasson; C W Jones; A Bauman; E John; J Manaligod; M O Tso
Journal:  Ann Surg       Date:  1985-01       Impact factor: 12.969

10.  Ocular fluorophotometry in the normal- and diabetic monkey.

Authors:  C W Jones; J G Cunha-Vaz; R C Zeimer; M M Rusin; P W Langenberg; C M Vygantas; M O Tso; O Jonasson
Journal:  Exp Eye Res       Date:  1986-05       Impact factor: 3.467

View more
  8 in total

1.  Assessment of perfused foveal microvascular density and identification of nonperfused capillaries in healthy and vasculopathic eyes.

Authors:  Alexander Pinhas; Moataz Razeen; Michael Dubow; Alexander Gan; Toco Y Chui; Nishit Shah; Mitul Mehta; Ronald C Gentile; Rishard Weitz; Joseph B Walsh; Yusufu N Sulai; Joseph Carroll; Alfredo Dubra; Richard B Rosen
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-20       Impact factor: 4.799

2.  Progression of Diabetic Capillary Occlusion: A Model.

Authors:  Xiao Fu; John Scott Gens; James A Glazier; Stephen A Burns; Thomas J Gast
Journal:  PLoS Comput Biol       Date:  2016-06-14       Impact factor: 4.475

3.  Retinal neovascularisation without ischaemia in the spontaneously diabetic Torii rat.

Authors:  H Yamada; E Yamada; A Higuchi; M Matsumura
Journal:  Diabetologia       Date:  2005-06-24       Impact factor: 10.122

4.  Pathological changes in human retinal ganglion cells associated with diabetic and hypertensive retinopathy.

Authors:  Birthe Meyer-Rüsenberg; Mitrofanis Pavlidis; Tobias Stupp; Solon Thanos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12-21       Impact factor: 3.535

Review 5.  Choosing preclinical study models of diabetic retinopathy: key problems for consideration.

Authors:  Xue-Song Mi; Ti-Fei Yuan; Yong Ding; Jing-Xiang Zhong; Kwok-Fai So
Journal:  Drug Des Devel Ther       Date:  2014-11-18       Impact factor: 4.162

6.  Hyperhexosemia-Induced Retinal Vascular Pathology in a Novel Primate Model of Diabetic Retinopathy.

Authors:  Argyrios Chronopoulos; Sumon Roy; Ekaterina Beglova; Keith Mansfield; Lynn Wachtman; Sayon Roy
Journal:  Diabetes       Date:  2015-03-02       Impact factor: 9.461

7.  Extensive Sub-RPE Complement Deposition in a Nonhuman Primate Model of Early-Stage Diabetic Retinopathy.

Authors:  Shuxin Fan; Ziqi Yang; Yan Liu; Jiawei Zhong; Shuyao Zhang; Yuhua Xiao; Xu Liu; Wei Yi; Chang He; Youjin Hu; Xialin Liu
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-03-01       Impact factor: 4.799

Review 8.  Diabetic Retinopathy: From Animal Models to Cellular Signaling.

Authors:  Priyamvada M Pitale; Marina S Gorbatyuk
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.